Shalabh K. Gupta Unicycive Therapeutics, Inc. (UNCY) insider trading activity
Shalabh K. Gupta is CEO of Unicycive Therapeutics, Inc.. Currently has a direct ownership of 2.53 Million shares of UNCY, which is worth approximately $1.26 Million. The most recent transaction as insider was on Jul 11, 2023, when has been sold 104,612 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.53M
0%
3M change
0%
12M change
Total Value Held
$1.26 Million
SKG
Shalabh K. Gupta
CEO
Los Altos, CA